Literature DB >> 10438183

Stability of the X-ray contrast agent iodixanol=3,3',5,5'-tetrakis(2,3-dihydroxypropylcarbamoyl)- 2,2',4,4',6, 6'-hexaiodo-N,N'-(2-hydroxypropane-1,3-diyl)-diacetanili de towards acid, base, oxygen, heat and light.

H Priebe1, A Aukrust, H R Bjørsvik, C P Tønseth, U N Wiggen.   

Abstract

BACKGROUND: During the production process of the X-ray contrast agent iodixanol the drug substance may be exposed to acid, base, air, heat and daylight, conditions that may cause decomposition products.
OBJECTIVE: To investigate the chemical stability of iodixanol under accelerating conditions.
METHOD: Chemometrical stability studies were undertaken to investigate the effect of acid and base on the contrast agent's stability.
RESULTS: Cleavage of the central bridge in iodixanol occurred under ultraviolet irradiation via a Norrish Type-II reaction. Basic conditions (pH 14) combined with heat (60 degrees C) initiated a cyclization reaction. Less than 1% iodixanol decomposed in solution heated to 140 degrees C for 2 days or under both basic conditions (pH 11, 20 degrees C, 5 days) and acidic conditions (pH 0.4, 80 degrees C, 5 days) or under oxygen atmosphere (100 degrees C, 3 days).
CONCLUSION: Even under highly acidic and basic conditions, iodixanol is stable.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438183     DOI: 10.1046/j.1365-2710.1999.00225.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  1 in total

1.  Sensitive label-free imaging of brain samples using FxClear-based tissue clearing technique.

Authors:  Boram Lee; Eunsoo Lee; June Hoan Kim; Hyung-Jin Kim; Yong Guk Kang; Hyun Jung Kim; Jin-Kyoung Shim; Seok-Gu Kang; Beop-Min Kim; Karam Kim; Youseok Kim; Keunchang Cho; Woong Sun
Journal:  iScience       Date:  2021-03-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.